Dyslipidemia
Showing 1 - 25 of 348
Dyslipidemia Trial in Seoul (Rosuvastatin Immediate-Release Tablet (IRT) 10mg, Rosuvastatin orally disintegrating tablet
Recruiting
- Dyslipidemia
- Rosuvastatin Immediate-Release Tablet (IRT) 10mg
- Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg
-
Seoul, Korea, Republic ofDivision of Cardiology, Department of Internal Medicine, Yonsei
Nov 22, 2023
Epicardial Fat Thickness in Children With Familial Dyslipidemia
Not yet recruiting
- Dyslipidemia
- echoCARDIOGRAPHY
- (no location specified)
Oct 22, 2023
Sickle Cell Disease, Dyslipidemia, Complication Trial in Pointe-à-Pitre, Le Lamentin (HDL2)
Recruiting
- Sickle Cell Disease
- +2 more
- HDL2
-
Pointe-à-Pitre, Guadeloupe, France
- +1 more
Mar 21, 2023
Lipoprotein Metabolism in Normal Volunteers and High Levels of
Completed
- Hypolipoproteinemia
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Dyslipidemia, Atherosclerosis, Acute Coronary Syndrome Trial in Dallas (RVX000222, Placebo)
Completed
- Dyslipidemia
- +3 more
- RVX000222
- Placebo
-
Dallas, TexasCovance Clinical Research Unit, Inc.
Nov 1, 2022
Dyslipidemia Trial in Japan (Part A:Placebo, Part A:AZD8233, Part B:Placebo)
Completed
- Dyslipidemia
- Part A:Placebo
- +5 more
-
Chiyoda-ku, Japan
- +6 more
Oct 3, 2022
Dyslipidemia, Atherosclerosis, Diabetes, Type 2 Trial (Choline fenofibrate, Policosanol)
Recruiting
- Dyslipidemia
- +2 more
- Choline fenofibrate
- Policosanol
-
Seongnam, Gyeonggi, Korea, Republic ofSNUBH
Oct 1, 2022
Diabetes, Myocardial Infarction, Stroke Trial in United States (Lifestyle Intervention, Diabetes Support and Education)
Completed
- Diabetes
- +5 more
- Lifestyle Intervention
- Diabetes Support and Education
-
Birmingham, Alabama
- +17 more
Sep 27, 2022
Treatment of Newvast® Tab(Atorvastatin) in Korean Dyslipidemia
Completed
- Dyslipidemia
- single arm, single group(No interventional)
-
Seoul, Korea, Republic ofHanmi Pharmaceutical Company Limited
Sep 22, 2022
Dyslipidemia and Diabetic Retinopathy
Recruiting
- Diabetic Retinopathy
- Dyslipidemia
- 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy
- Healthy Controls 15 age matched control subjects
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 11, 2022
Type 2 Diabetes, Dyslipidemia Trial (BERLIM 25/10 association, EMPAGLIFLOZIN, ROSUVASTATIN CALCIUM)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Dyslipidemia
- BERLIM 25/10 association
- +5 more
- (no location specified)
Aug 3, 2022
Hypertriglyceridemia, Dyslipidemia Trial in Campinas (Cipros 10 association, Crestor 10 mg)
Recruiting
- Hypertriglyceridemia
- Dyslipidemia
- Cipros 10 association
- Crestor 10 mg
-
Campinas, São Paulo, BrazilAllergisa
Aug 3, 2022
Effectiveness and Safety of Amosartan Q Tablet
Completed
- Hypertension
- Dyslipidemia
- Amosartan Q tablet
-
Seoul, Korea, Republic ofHanmi Pharmaceutical Company Limited
Jul 5, 2022
"My A:Care" and "Smart Coach" on Lipid-lowering Treatment
Recruiting
- Dyslipidemia
- My A:care
- Smart Coach
-
Khon Kaen, ThailandChatlert Mueang Pongchaiyakul
May 9, 2022
Dyslipidemia, Hypertension Trial in Seoul (LivaloVA, LivaloV, VA)
Recruiting
- Dyslipidemia
- Hypertension
- LivaloVA
- +2 more
-
Seoul, Korea, Korea, Republic ofGangdong Sacred Heart Hospital
Apr 10, 2022
Dyslipidemia Trial in Worldwide (Evolocumab)
Completed
- Dyslipidemia
- Evolocumab
-
Birmingham, Alabama
- +197 more
Apr 4, 2022
Dyslipidemia Trial in Worldwide (survey)
Active, not recruiting
- Dyslipidemia
- survey
-
Kuwait, Kuwait
- +3 more
Mar 7, 2022